Company data
Benitec Biopharma Inc. employees and revenue per employee
BNTC · Biotechnology · $305M market cap
Benitec Biopharma Inc. had 18 employees at the end of fiscal Jun 2023, unchanged from a year earlier. Revenue for the year was $75,000, up 2.7% from a year earlier, or $4K per employee. Revenue held up or grew while headcount stayed flat or fell.
The latest annual report we hold is more than two years old, so these numbers may be out of date.
Employees
18
+0.0% YoY
Revenue
$75,000
+2.7% YoY
Revenue / employee
$4K
Peer median $458K
Rank in industry
106 of 109
Biotechnology
Headcount against revenue
Both lines start at 100 in the first year we hold, so you can see which one grew faster.
Hover a year for the numbers.
| Year ending | Employees | Revenue | Per employee | Staff YoY | Revenue YoY |
|---|---|---|---|---|---|
| Jun 2023 | 18 | $75,000 | $4K | +0.0% | +2.7% |
| Jun 2022 | 18 | $73,000 | $4K | +28.6% | +23.7% |
| Jun 2021 | 14 | $59,000 | $4K | +0.0% | -39.2% |
| Jun 2020 | 14 | $97,000 | $7K | — | — |
Open roles: we have not matched a verified job board for this company yet.
Benitec Biopharma Inc. against similar companies
The closest industry peers by revenue, from Biotechnology.
| Company | Employees | Revenue | Revenue / employee | Shape |
|---|---|---|---|---|
| STTK Shattuck Labs, Inc. | 40 | $1.0M | $25K | Contracting |
| DNTH Dianthus Therapeutics, Inc. | 92 | $2.0M | $22K | Hiring into decline |
| ABSI Absci Corporation | 140 | $2.8M | $20K | Contracting |
| INBX Inhibrx Biosciences Inc. | 109 | $1.3M | $12K | Leaner |
| NGNE Neurogene Inc. | 107 | $925,000 | $9K | — |
| CLDX Celldex Therapeutics, Inc. | 198 | $1.5M | $8K | Hiring into decline |
| BNTC Benitec Biopharma Inc. | 18 | $75,000 | $4K | Leaner |
| ARTV Artiva Biotherapeutics, Inc. | 89 | $251,000 | $3K | — |
| AVTX Avalo Therapeutics, Inc. | 33 | $59,000 | $2K | Hiring into decline |
Questions about Benitec Biopharma Inc.
- How many employees does Benitec Biopharma Inc. have?
- Benitec Biopharma Inc. reported 18 employees for the fiscal year ending Jun 2023, in the annual report it filed on September 21, 2023. That is unchanged from a year earlier.
- What is Benitec Biopharma Inc.'s revenue per employee?
- Benitec Biopharma Inc. brought in $75,000 of revenue in fiscal Jun 2023, which is $4K per employee. That ranks 106 of 109 companies we track in Biotechnology, where the median is $458K.
- Where do these numbers come from?
- Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.
Free game
Think you can pick better than the S&P 500?
Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.
Enter the challengeMore data
Compare BNTC with the rest of the market
See who earns the most per employee, who is hiring, and who is cutting, across every company we track.
Source: employee counts and revenue as stated in Benitec Biopharma Inc.'s annual reports (Form 10-K), latest filed September 21, 2023. This is data, not a recommendation to buy or sell BNTC.